Soaring Eagle Acquisition Corp.
SRNGW
NASDAQ Global Select3.02
USD
+0.32
- -
Soaring Eagle Acquisition Corp.
SRNGW
(NASDAQ Global Select)
Recent
price
3.02
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Soaring Eagle Acquisition Corp. (SRNGW) is a blank check company, or special purpose acquisition company (SPAC), whose principal business activity is to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company does not have substantial operations of its own and holds cash raised from its initial public offering in trust pending identification and completion of an initial business combination; its public warrants (SRNGW) entitle holders to purchase Class A ordinary shares at an exercise price of $11.50 per share upon satisfaction of certain conditions. Incorporated in 2020 and headquartered in New York, New York, with additional addresses referenced in Los Angeles, California, the company operates in the financial services sector, specifically within shell companies, targeting opportunities across industries, sectors, and geographic regions without limitation. In 2021, Soaring Eagle Acquisition Corp. entered into a definitive agreement on May 11 for a business combination with Ginkgo Bioworks, Inc., pursuant to which it would acquire all outstanding equity interests of Ginkgo in a reverse merger transaction valued at approximately $15 billion in pre-money equity consideration, plus up to 180 million earn-out shares, along with a concurrent $775 million private investment in public equity (PIPE) financing. The merger was approved by Soaring Eagle's board on May 7, 2021, and shareholders on September 14, 2021, with the transaction closing on or about September 16, 2021; upon completion, Soaring Eagle domesticated from the Cayman Islands to Delaware, changed its name to Ginkgo Bioworks Holdings, Inc., and listed its Class A common stock and warrants on the New York Stock Exchange, while Ginkgo became its wholly owned subsidiary. The SRNGW warrants continued trading post-merger as adjusted warrants to acquire shares of the successor entity, with no reported further mergers, acquisitions, funding rounds, or material operational changes for Soaring Eagle itself in the last 1-2 years as of late 2025. The sponsor is Eagle Equity Partners III, LLC, led by Managing Members Harry E. Sloan (Chairman and CEO), Jeff Sagansky, and Eli Baker (President, CFO, and Secretary).
Ginkgo Bioworks to Go Public with Over $1.6 Billion in Proceeds
Soaring Eagle Announces Achievement of Quorum to Pass Proposed Business Combination with Ginkgo, Proxies Received Indicate Overwhelming Support for All Proposals